Cargando…

Locoregional Therapy in De novo Metastatic Breast Cancer: A Retrospective Cohort Study

Objective: Whether locoregional therapy (LRT) should be performed in patients with de novo metastatic breast cancer (dnMBC) has been debated. Here we report the survival outcomes of LRT in patients with dnMBC, focusing on the association of surgical timings and surgical margins with survival in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jianna, Sun, Lingjun, Kong, Nana, Feng, Hong, Liu, Chongxi, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340403/ https://www.ncbi.nlm.nih.gov/pubmed/35899318 http://dx.doi.org/10.1177/15330338221115356

Ejemplares similares

Locoregional therapy in de novo metastatic breast cancer. The unanswered question
por: Cardoso, Maria-Joao, et al.
Publicado: (2021)

Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
por: Reinhorn, Daniel, et al.
Publicado: (2021)

Role of Locoregional Treatment in De Novo Stage IV Breast Cancer
por: Lee, Joanna S, et al.
Publicado: (2020)

Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy
por: Hu, Y.-J., et al.
Publicado: (2023)

Prognostic Score for De Novo Metastatic Breast Cancer With Liver Metastasis and Its Predictive Value of Locoregional Treatment Benefit
por: Ji, Lei, et al.
Publicado: (2021)

Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study
por: Zeng, Fujuan, et al.
Publicado: (2021)

The role and indications of aggressive locoregional therapy in metastatic inflammatory breast cancer
por: Yan, Yi, et al.
Publicado: (2016)

Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology
por: Merloni, Filippo, et al.
Publicado: (2023)

Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
por: Chen, Peng-Yu, et al.
Publicado: (2013)

Effect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital
por: Bianchini, Diletta, et al.
Publicado: (2017)

The Prognostic Value of Locoregional Interventions for BRAF V600E Metastatic Colorectal Cancer: A Retrospective Cohort Analysis
por: Ye, Liu-Fang, et al.
Publicado: (2021)

Prognostic value of pre-treatment FDG PET/CT SUVmax for metastatic lesions in de novo metastatic nasopharyngeal carcinoma following chemotherapy and locoregional radiotherapy
por: Yan, Wenbin, et al.
Publicado: (2023)

Correspondence to “Locoregional therapy in de novo metastatic breast cancer: Systematic review and meta-analysis, written by Reinhorn D et al. In The Breast Journal 58 (2021) 173–181”
por: Soran, Atilla, et al.
Publicado: (2021)

Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis
por: Yao, Yuyi, et al.
Publicado: (2023)

Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis
por: Du, Chengrun, et al.
Publicado: (2022)

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
por: Yang, Jin-Hao, et al.
Publicado: (2021)

Metastatic disease to the liver: Locoregional therapy strategies and outcomes
por: Zane, Kylie E, et al.
Publicado: (2021)

Prognostic model for risk stratification of de novo metastatic nasopharyngeal carcinoma patients treated with chemotherapy followed by locoregional radiotherapy
por: Li, W.-Z., et al.
Publicado: (2021)

Locoregional therapy of the primary tumour in de novo stage IV breast cancer in 216 066 patients: A meta-analysis
por: Gera, Ritika, et al.
Publicado: (2020)

Bone metastases in breast cancer: Frequency, metastatic pattern and non-systemic locoregional therapy
por: Steinauer, Kirsten, et al.
Publicado: (2014)

Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study
por: Ma, Yuyu, et al.
Publicado: (2022)

Locoregional tumor burden and risk of mortality in metastatic breast cancer
por: Yang, Sherry X., et al.
Publicado: (2022)

Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020)

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis
por: Santini, Daniele, et al.
Publicado: (2017)

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
por: Chan, Arlene, et al.
Publicado: (2012)

Locoregional Treatments for Metastatic Gastrointestinal Stromal Tumor in British Columbia: A Retrospective Cohort Study from January 2008 to December 2017
por: Patterson, Tiffany, et al.
Publicado: (2022)

Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress
por: DePalo, Danielle K., et al.
Publicado: (2023)

Aggressive local therapy for de novo metastatic breast cancer: Challenges and updates (Review)
por: Liu, Bailong, et al.
Publicado: (2023)

An observational retrospective analysis of the main metastatic site and corresponding locoregional treatment as a prognostic factor in metastatic gastric cancer
por: Giampieri, Riccardo, et al.
Publicado: (2021)

Optimizing the Treatment Pattern for De Novo Metastatic Nasopharyngeal Carcinoma Patients: A Large-Scale Retrospective Cohort Study
por: Sun, Xue-Song, et al.
Publicado: (2020)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

Locoregional therapy of renal cancer
por: Wah, Tze Min
Publicado: (2014)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
por: Lobbezoo, D J A, et al.
Publicado: (2015)

The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study
por: Lee, Kyoungmin, et al.
Publicado: (2021)

The Place of Extensive Surgery in Locoregional Recurrence and Limited Metastatic Disease of Breast Cancer: Preliminary Results
por: Berlière, M., et al.
Publicado: (2015)

Individualized Prediction of Survival Benefit From Locoregional Surgical Treatment for Patients With Metastatic Breast Cancer
por: Zheng, Yajuan, et al.
Publicado: (2020)

Imaging in Locoregional Management of Breast Cancer
por: Kuhl, Christiane K., et al.
Publicado: (2020)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Trastuzumab therapy duration in HER2-positive de novo metastatic breast cancer: 1999–2018
por: Kaplan, Henry G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3aa1feibh2j38rnshvpsad4uod